Your search:
3 result(s) in 0.05 s
-
DUKAS_186624859_NUR
Mexico’s President Claudia Sheinbaum Presents Plan Mexico
Executive Chairman of the Board of Neolpharma Group, Diego Antonio Gutierrez de Velasco, speaks during the presentation of Plan Mexico to the national pharmaceutical industry with the companies Laboratorios Kener and Grupo Neolpharma for the manufacturing of specialized medications in Mexico at a news conference at the National Palace in Mexico City, Mexico, on July 3, 2025. (Photo by Luis Barron/Eyepix Group) (Photo by Eyepix/NurPhoto) -
DUKAS_186624952_NUR
Mexico’s President Claudia Sheinbaum Presents Plan Mexico
The CEO of Neolpharma Group, Luz Astrea Ocampo Gutierrez de Velasco, speaks during the presentation of Plan Mexico to the national pharmaceutical industry with the companies Laboratorios Kener and Grupo Neolpharma for the manufacturing of specialized medications in Mexico at a news conference at the National Palace in Mexico City, Mexico, on July 3, 2025. (Photo by Luis Barron/Eyepix Group) -
DUKAS_186624939_NUR
Mexico’s President Claudia Sheinbaum Presents Plan Mexico
The CEO of Neolpharma Group, Luz Astrea Ocampo Gutierrez de Velasco, speaks during the presentation of Plan Mexico to the national pharmaceutical industry with the companies Laboratorios Kener and Grupo Neolpharma for the manufacturing of specialized medications in Mexico at a news conference at the National Palace in Mexico City, Mexico, on July 3, 2025. (Photo by Luis Barron/Eyepix Group)